Motorized Spiral Enteroscopy-assisted ERCP in Surgically Altered Anatomy
1 other identifier
observational
35
1 country
1
Brief Summary
Patients with surgically altered anatomy receiving Motorized Spiral Eneroscopy (MSE)-assisted ERCP at a single endoscopic reference center for various indications are planned to be retrospectively enrolled
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedFirst Posted
Study publicly available on registry
June 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedJune 21, 2021
June 1, 2021
3 months
May 28, 2021
June 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Success rate of MSE-ERCP
rate of subjects with successfull MSE-assisted ERCP
intraprocedural
Adverse event rate of MSE-ERCP
rate of adverse events during and early after MSE-ERCP
3 days
Secondary Outcomes (2)
Success rate of enteroscopy
intraprocedural
Procedural duration
intraprocedural
Study Arms (1)
MSE-ERCP
Group of patients, that received motorized spiral enteroscopy assisted ERCP in altered anatomy at the single study center
Interventions
No interventional study, MSE-ERCP performed within routine treatment, (approved indication of device)
Eligibility Criteria
Patients with surgically altered upper gastrointestinal anatomy and indication for endoscopic retrograde cholangio-pancreatography
You may qualify if:
- altered upper gastrointestinal anatomy after Billroth-II- or Roux-en-Y reconstructive surgery
- indication for ERCP with biliary and/or pancreatic indication
- Enteroscopy-assisted ERCP using MSE, at the study center during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Evangelisches Krankenhaus
Düsseldorf, 40217, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Torsten Beyna, MD PhD
Evangelisches Krankenhaus Düsseldorf, Department of Gastroenterology and Therapeutic Endoscopy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2021
First Posted
June 3, 2021
Study Start
June 1, 2021
Primary Completion
September 1, 2021
Study Completion
October 1, 2021
Last Updated
June 21, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share
No exchange of individual data is planned